Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

This course is free with a membership upgrade!

Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.

Get access starting at $49.99/yrLoading..
Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
The goal of this course is to provide an introduction to autoimmune disease causes, treatment, and overall management.
Goals and Outcomes
Goals and Learning Outcomes
Autoimmune diseases are a group of more than 80 disorders in which one’s adaptive immune system attacks itself (Medline Plus, 2022). Autoimmune diseases can be localized or systemic and are the third most prominent group of disorders with varying etiologies (Angum et al., 2020; Desai & Brinton, 2019). Females are twice as likely to experience an autoimmune disorder when compared to males (Angum et al., 2020). This educational activity will focus on rheumatic autoimmune diseases (i.e., affecting the joints, muscles, or fibrous tissue) as this is the most prevalent autoimmune specialty. Other common autoimmune diseases and some rare disorders treated by other specialists will also be discussed. The goal of this course is to provide an introduction to autoimmune disease causes, treatment, and overall management.

After taking this course, you should be able to:

  • Discuss at least four causes of autoimmune diseases
  • List two reasons for female predominance in autoimmune diseases
  • Describe general treatments for autoimmune diseases
  • Recall the pathophysiology of the adaptive immune system vs. the innate immune system and potential causes of autoimmune diseases.
  • Identify common autoimmune diseases, complications related to autoimmune diseases, various treatment approaches, and the impact of COVID-19 and other viruses on autoimmune dysfunction.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 04/01/22
Details
Course Details

Course Originally Released on : 4/1/2022

REL-ACU-0-ADCT

Course Author

Shalla Newton

MSN, RN, NE-BC

Damaris Vieira

MS, ARNP, NP-C

Maureen Habel

MA, RN

Laura Bell

BSN, RN, CCRN

Debra Anscombe Wood

BS, RN

Valerie Probstfeld

MSN, RN, FNP-BC

Connie C. Chettle

MS, MPH, RN

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.